Here, we demonstrate that compromised GLT-1-mediated uptake, either through pharmacological inhibition or in the 3xTg mouse model of AD, slows glutamate clearance to a greater extent at presynaptic compared to postsynaptic membranes in the hippocampus. The gene discussed is SLC1A2; the disease is Alzheimer disease.